Inhibrx Biosciences, Inc. - INBX
Ownership (Schedule 13D / 13G) · latest 50 filings
· Back to all files
Visible: 0
| Filed | Form | Reporting person | Percent | Shares | SEC |
|---|---|---|---|---|---|
| Aug 14, 2026 | SCHEDULE 13G/A | Perceptive Advisors LLC | 9.99% | 1,489,443 | View |
| Aug 14, 2026 | SCHEDULE 13G/A | Joseph Edelman | 9.99% | 1,489,443 | View |
| Aug 14, 2026 | SCHEDULE 13G/A | Perceptive Life Sciences Master Fund, Ltd. | 9.99% | 1,489,443 | View |
| Aug 14, 2026 | SCHEDULE 13G | Schonfeld Strategic Advisors LLC | 5.33% | 781,678 | View |
| Aug 14, 2026 | SCHEDULE 13G/A | VIKING GLOBAL INVESTORS LP | 9.3% | 1,383,621 | View |
| Aug 14, 2026 | SCHEDULE 13G/A | Viking Global Opportunities Parent GP LLC | 9.3% | 1,383,621 | View |
| Aug 14, 2026 | SCHEDULE 13G/A | Viking Global Opportunities GP LLC | 8.7% | 1,303,208 | View |
| Aug 14, 2026 | SCHEDULE 13G/A | Viking Global Opportunities Portfolio GP LLC | 8.4% | 1,250,816 | View |
| Aug 14, 2026 | SCHEDULE 13G/A | Viking Global Opportunities Illiquid Investments Sub-Master LP | 8.4% | 1,250,816 | View |
| Aug 14, 2026 | SCHEDULE 13G/A | KAVRA 104 LLC | 0.4% | 52,392 | View |
| Aug 14, 2026 | SCHEDULE 13G/A | Viking Global Opportunities Drawdown GP LLC | 0.5% | 80,413 | View |
| Aug 14, 2026 | SCHEDULE 13G/A | Viking Global Opportunities Drawdown Portfolio GP LLC | 0.5% | 80,413 | View |
| Aug 14, 2026 | SCHEDULE 13G/A | Viking Global Opportunities Drawdown (Aggregator) LP | 0.5% | 80,413 | View |
| Aug 14, 2026 | SCHEDULE 13G/A | HALVORSEN OLE ANDREAS | 9.3% | 1,383,621 | View |
| Aug 14, 2026 | SCHEDULE 13G/A | Shabet Rose Sharon | 9.3% | 1,383,621 | View |
| Aug 03, 2026 | SCHEDULE 13G | BANK OF AMERICA CORP /DE/ | 5.9% | 857,318 | View |
| May 15, 2026 | SCHEDULE 13G/A | VIKING GLOBAL INVESTORS LP | 9.99% | 1,461,633 | View |
| May 15, 2026 | SCHEDULE 13G/A | Viking Global Opportunities Parent GP LLC | 9.99% | 1,461,633 | View |
| May 15, 2026 | SCHEDULE 13G/A | Viking Global Opportunities GP LLC | 9.3% | 1,358,769 | View |
| May 15, 2026 | SCHEDULE 13G/A | Viking Global Opportunities Portfolio GP LLC | 8.8% | 1,291,751 | View |
| May 15, 2026 | SCHEDULE 13G/A | Viking Global Opportunities Illiquid Investments Sub-Master LP | 8.8% | 1,291,751 | View |
| May 15, 2026 | SCHEDULE 13G/A | KAVRA 104 LLC | 0.5% | 67,018 | View |
| May 15, 2026 | SCHEDULE 13G/A | Viking Global Opportunities Drawdown GP LLC | 0.7% | 102,864 | View |
| May 15, 2026 | SCHEDULE 13G/A | Viking Global Opportunities Drawdown Portfolio GP LLC | 0.7% | 102,864 | View |
| May 15, 2026 | SCHEDULE 13G/A | Viking Global Opportunities Drawdown (Aggregator) LP | 0.7% | 102,864 | View |
| May 15, 2026 | SCHEDULE 13G/A | HALVORSEN OLE ANDREAS | 9.99% | 1,461,633 | View |
| May 15, 2026 | SCHEDULE 13G/A | Shabet Rose Sharon | 9.99% | 1,461,633 | View |
| May 15, 2026 | SCHEDULE 13G/A | Perceptive Advisors LLC | 9.99% | 1,461,105 | View |
| May 15, 2026 | SCHEDULE 13G/A | Joseph Edelman | 9.99% | 1,461,105 | View |
| May 15, 2026 | SCHEDULE 13G/A | Perceptive Life Sciences Master Fund, Ltd. | 9.99% | 1,461,105 | View |
Percent = "% of class represented by amount beneficially owned" for this reporting person in the filed 13D/13G.
Shares = reported beneficial ownership amount for the same row (not portfolio shares from 13F).
Amendments (/A) can repeat the same holder over time, so rows should not be summed.
Extraction is best-effort from filing text and can be missing or noisy; verify exact figures via the SEC link in each row.